Optimizing Screening for Osteoporosis in Patients With Fragility Hip Fracture

被引:28
|
作者
Roy, Archana [2 ]
Heckman, Michael G. [3 ]
O'Connor, Mary I. [1 ]
机构
[1] Mayo Clin, Dept Orthoped Surg, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Internal Med, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Biostat, Jacksonville, FL 32224 USA
关键词
BONE-DENSITY; RISK; MEN;
D O I
10.1007/s11999-011-1839-5
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Osteoporosis, the underlying cause of most hip fractures, is underdiagnosed and undertreated. The 2008 Joint Commission report Improving and Measuring Osteoporosis Management showed only an average of 20% of patients with low-impact fracture are ever tested or treated for osteoporosis. We developed an integrated model utilizing hospitalists and orthopaedic surgeons to improve care of osteoporosis in patients with hip fracture. Does our integrated model combining hospitalists and orthopaedic surgeons improve the frequency of evaluation for osteoporosis, screening for secondary causes, and patients' education on osteoporosis? Our Hospitalist-Orthopaedic Surgeon Integrated Model of Care was implemented in September 2009. We compared the rate of evaluation and treatment of osteoporosis in 140 patients admitted with fragility hip fracture at our institution before (70 patients) and after (70 patients) implementation of the care plan. Evaluation of patients for osteoporosis was higher in the postimplementation group compared to the preimplementation group (89% versus 24%). Screening of patients for secondary causes of osteoporosis was also improved in the postimplementation group (89% versus 0%), as was the proportion of patients who received education for osteoporosis management (89% versus 0%). Our model of integrated care by hospitalists and orthopaedic surgeons resulted in improvement in the evaluation for osteoporosis, screening for secondary causes of osteoporosis, and education on osteoporosis management in patients with hip fracture at our institution. This may have important implications for treatment of these patients. Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
引用
收藏
页码:1925 / 1930
页数:6
相关论文
共 50 条
  • [31] Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures
    Gupta, M. J.
    Shah, S.
    Peterson, S.
    Baim, S.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (08) : 1861 - 1874
  • [32] The aftermath of hip fragility fractures are we missing out on osteoporosis treatment?
    Costa, R.
    Romano, J.
    Moreira, A.
    Dantas, D.
    Ribeiro, P.
    Agre, M.
    Correia, J.
    ACTA REUMATOLOGICA PORTUGUESA, 2021, 46 (04): : 328 - 332
  • [33] Analysis of Related Factors of Brittle Hip Fracture in Postmenopausal Women with Osteoporosis
    Zhuang, Hua-feng
    Wang, Pei-wen
    Li, Yi-zhong
    Lin, Jin-kuang
    Yao, Xue-dong
    Xu, Hao
    ORTHOPAEDIC SURGERY, 2020, 12 (01) : 194 - 198
  • [34] Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
    Masud, Tahir
    McClung, Michael
    Geusens, Piet
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 445 - 449
  • [35] Handgrip strength as a predictor of one-year mortality in elderly patients with fragility hip fracture
    Salis, Francesco
    Buffoli, Irene
    Belfiori, Maristella
    Bellisai, Alice
    Gianoglio, Benedetta
    Marongiu, Giuseppe
    Marzuolo, Monia
    Navarra, Giuseppe
    Piras, Veronica
    Puxeddu, Benedetta
    Sanna, Luisa
    Scudu, Chiara
    Capone, Antonio
    Mandas, Antonella
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2025, 37 (01)
  • [36] Subsequent Hip Fracture in Osteoporotic Hip Fracture Patients
    Lee, Sang Ho
    Lee, Tong Joo
    Cho, Kyu Jung
    Shin, Sang Hyun
    Moon, Kyoung Ho
    YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 1005 - 1009
  • [37] Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture
    Wang, Pei-wen
    Li, Yi-zhong
    Zhuang, Hua-feng
    Yu, Hai-ming
    Cai, Si-qing
    Xu, Hao
    Chen, Zhen-hui
    Lin, Jin-kuang
    Yao, Xue-dong
    ORTHOPAEDIC SURGERY, 2019, 11 (05) : 777 - 783
  • [38] Screening for osteoporosis reduced new fracture incidence by almost half A 6-year follow-up of 592 fracture patients from an osteoporosis screening program
    Astrand, Jorgen
    Nilsson, Johan
    Thorngren, Karl-Goran
    ACTA ORTHOPAEDICA, 2012, 83 (06) : 661 - 665
  • [39] Mortality and physical dependence following fragility hip fracture: data from a regional hip fracture registry in Sri Lanka
    Lekamwasam, Sarath
    Sabapathippillai, Saumyarika
    ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
  • [40] Contralateral hip fractures and other osteoporosis-related fractures in hip fracture patients: incidence and risk factors. An observational cohort study of 1,229 patients
    Vochteloo, Anne J. H.
    van der Burg, Boudewijn L. S. Borger
    Roling, Maarten A.
    van Leeuwen, Diederik H.
    van den Berg, Peter
    Niggebrugge, Arthur H. P.
    de Vries, Mark R.
    Tuinebreijer, Wim E.
    Bloem, Rolf M.
    Nelissen, Rob G. H. H.
    Pilot, Peter
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2012, 132 (08) : 1191 - 1197